PD-L1 CAR haNKs killed IFNγ pre-treated murine HNSCC cells in a dose-dependent fashion, with 70–80% cell killing at a 1:1 effector-to-target ratio (Figure 2—figure supplement 1). This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.